These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33940009)

  • 1. The functional role of decorin in corneal neovascularization in vivo.
    Balne PK; Gupta S; Zhang J; Bristow D; Faubion M; Heil SD; Sinha PR; Green SL; Iozzo RV; Mohan RR
    Exp Eye Res; 2021 Jun; 207():108610. PubMed ID: 33940009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-targeted and localized AAV5-DCN and AAV5-PEDF combination gene therapy abrogates corneal fibrosis and concurrent neovascularization in rabbit eyes in vivo.
    Mohan RR; Gupta S; Kumar R; Sinha NR; Landreneau J; Sinha PR; Tandon A; Chaurasia SS; Hesemann NP
    Ocul Surf; 2024 Apr; 32():13-25. PubMed ID: 38191093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decorin regulates collagen fibrillogenesis during corneal wound healing in mouse in vivo.
    Gupta S; Buyank F; Sinha NR; Grant DG; Sinha PR; Iozzo RV; Chaurasia SS; Mohan RR
    Exp Eye Res; 2022 Mar; 216():108933. PubMed ID: 35031282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted decorin gene therapy delivered with adeno-associated virus effectively retards corneal neovascularization in vivo.
    Mohan RR; Tovey JC; Sharma A; Schultz GS; Cowden JW; Tandon A
    PLoS One; 2011; 6(10):e26432. PubMed ID: 22039486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of mouse alkali burn induced-corneal neovascularization by recombinant adenovirus encoding human vasohibin-1.
    Zhou SY; Xie ZL; Xiao O; Yang XR; Heng BC; Sato Y
    Mol Vis; 2010 Jul; 16():1389-98. PubMed ID: 20680097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six-Month In Vivo Safety Profiling of Topical Ocular AAV5-Decorin Gene Transfer.
    Mohan RR; Balne PK; Muayad MS; Tripathi R; Sinha NR; Gupta S; An JA; Sinha PR; Hesemann NP
    Transl Vis Sci Technol; 2021 Aug; 10(10):5. PubMed ID: 34383877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of C-X-C chemokine receptor type 5 in the cornea and role in the inflammatory response after corneal injury.
    Balne PK; Gupta S; Landon KM; Sinha NR; Hofmann AC; Hauser N; Sinha PR; Huang H; Kempuraj D; Mohan RR
    Exp Eye Res; 2023 Jan; 226():109312. PubMed ID: 36400287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of PDGF receptor inhibitors and PI3-kinase signaling in the pathogenesis of corneal neovascularization.
    Dell S; Peters S; Müther P; Kociok N; Joussen AM
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):1928-37. PubMed ID: 16639000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical role of TNF-α-induced macrophage VEGF and iNOS production in the experimental corneal neovascularization.
    Lu P; Li L; Liu G; Baba T; Ishida Y; Nosaka M; Kondo T; Zhang X; Mukaida N
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3516-26. PubMed ID: 22570350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective Effect of TLR4 Ablation against Corneal Neovascularization following Chemical Burn in a Mouse Model.
    Friedman M; Azrad-Lebovitz T; Morzaev D; Zahavi A; Marianayagam NJ; Nicholson JD; Brookman M; Michowiz S; Hochhauser E; Goldenberg-Cohen N
    Curr Eye Res; 2019 May; 44(5):505-513. PubMed ID: 30595046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of corneal neovascularization by blocking the angiotensin II type 1 receptor.
    Usui T; Sugisaki K; Iriyama A; Yokoo S; Yamagami S; Nagai N; Ishida S; Amano S
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4370-6. PubMed ID: 18829859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant inhibition of corneal scarring in vivo with tissue-selective, targeted AAV5 decorin gene therapy.
    Mohan RR; Tandon A; Sharma A; Cowden JW; Tovey JC
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(7):4833-41. PubMed ID: 21551414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADP-ribosylation factor as a novel target for corneal neovascularization regression.
    Dai C; Liu G; Li L; Xiao Y; Zhang X; Lu P
    Mol Vis; 2012; 18():2947-53. PubMed ID: 23288987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical Role of IP-10 on Reducing Experimental Corneal Neovascularization.
    Liu G; Zhang W; Xiao Y; Lu P
    Curr Eye Res; 2015 Sep; 40(9):891-901. PubMed ID: 25309995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of tenascin X gene function impairs injury-induced stromal angiogenesis in mouse corneas.
    Sumioka T; Iwanishi H; Okada Y; Nidegawa Y; Miyajima M; Matsumoto KI; Saika S
    J Cell Mol Med; 2018 Feb; 22(2):948-956. PubMed ID: 29160014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex differences in corneal neovascularization in response to superficial corneal cautery in the rat.
    Irani YD; Pulford E; Mortimer L; Irani S; Butler L; Klebe S; Williams KA
    PLoS One; 2019; 14(9):e0221566. PubMed ID: 31479468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation.
    Shokirova H; Inomata T; Saitoh T; Zhu J; Fujio K; Okumura Y; Yanagawa A; Fujimoto K; Sung J; Eguchi A; Miura M; Nagino K; Hirosawa K; Kuwahara M; Akasaki Y; Nagase H; Murakami A
    Sci Rep; 2021 Apr; 11(1):8647. PubMed ID: 33883646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corneal neovascularization after excimer keratectomy wounds in matrilysin-deficient mice.
    Kure T; Chang JH; Kato T; Hernández-Quintela E; Ye H; Lu PC; Matrisian LM; Gatinel D; Shapiro S; Gosheh F; Azar DT
    Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):137-44. PubMed ID: 12506066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical role of SDF-1α-induced progenitor cell recruitment and macrophage VEGF production in the experimental corneal neovascularization.
    Liu G; Lu P; Li L; Jin H; He X; Mukaida N; Zhang X
    Mol Vis; 2011; 17():2129-38. PubMed ID: 21850188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of macrophage migration inhibitory factor in corneal neovascularization.
    Usui T; Yamagami S; Kishimoto S; Seiich Y; Nakayama T; Amano S
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3545-50. PubMed ID: 17652722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.